Enzon Pharmaceuticals, Inc. (BST:EZ1)

Market Cap	2.68M
Revenue (ttm)	n/a
Net Income (ttm)	-3.14M
Shares Out	n/a
EPS (ttm)	-0.04
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	2,567
Open	0.0300
Previous Close	0.0330
Day's Range	0.0300 - 0.0300
52-Week Range	0.0250 - 0.2300
Beta	n/a
RSI	41.69
Earnings Date	Feb 20, 2026

About Enzon Pharmaceuticals

Enzon Pharmaceuticals, Inc. does not have significant operations. Previously, it was engaged in the sale of its patented drug product, PegIntron. The company was formerly known as Enzon, Inc and changed its name to Enzon Pharmaceuticals, Inc. in December 2002. Enzon Pharmaceuticals, Inc. was incorporated in 1981 and is headquartered in Cranford, New Jersey.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 1981
• Employees: 1
• Stock Exchange: Stuttgart Stock Exchange
• Ticker Symbol: EZ1

Financial Performance

Financial numbers in USD